ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OLMA Olema Pharmaceuticals Inc

12.36
-0.10 (-0.80%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Olema Pharmaceuticals Inc OLMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.10 -0.80% 12.36 23:00:09
Open Price Low Price High Price Close Price Previous Close
12.37 12.14 12.78 12.36 12.46
more quote information »

Recent News

Date Time Source Heading
6/14/202415:39EDGAR2Form 8-K - Current report
6/06/202417:49EDGAR2Form SC 13D/A - General statement of acquisition of..
6/06/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202409:05EDGAR2Form 144 - Report of proposed sale of securities
6/06/202409:02EDGAR2Form 144 - Report of proposed sale of securities
6/04/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/04/202415:28GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
6/04/202414:09EDGAR2Form 144 - Report of proposed sale of securities
6/03/202413:55EDGAR2Form 144 - Report of proposed sale of securities
5/31/202411:17EDGAR2Form 144 - Report of proposed sale of securities
5/28/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/28/202406:03GLOBEOlema Oncology to Participate in Upcoming Investor..
5/15/202406:06EDGAR2Form 8-K - Current report
5/15/202406:01GLOBEOlema Oncology Announces Promising New Data for Palazestrant..
5/08/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202415:06EDGAR2Form 8-K - Current report
5/08/202415:02GLOBEOlema Oncology Reports First Quarter 2024 Financial Results..
5/08/202406:02GLOBEOlema Oncology Announces New Clinical Data for Palazestrant..
5/07/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/06/202415:00EDGAR2Form 144 - Report of proposed sale of securities
5/02/202415:37GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
5/01/202406:02GLOBEOlema Oncology to Participate in Upcoming Investor..
4/08/202415:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
4/02/202415:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
3/11/202415:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/11/202415:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/11/202415:05EDGAR2Form 8-K - Current report
3/11/202415:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
3/06/202406:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
3/04/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2/29/202413:26EDGAR2Form 144 - Report of proposed sale of securities
2/14/202415:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202411:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202416:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/11/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/06/202406:01GLOBEOlema Oncology to Participate in Upcoming Investor..
2/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2/01/202414:24EDGAR2Form 144 - Report of proposed sale of securities
1/31/202415:21EDGAR2Form S-3 - Registration statement under Securities Act of..
1/31/202413:58EDGAR2Form 144 - Report of proposed sale of securities
1/29/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202408:07EDGAR2Form 8-K - Current report
1/08/202407:18EDGAR2Form 8-K - Current report
1/08/202407:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
1/05/202416:26EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock